{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:33Z","timestamp":1791475353750,"version":"4.3.4"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP250102295"],"award-info":[{"award-number":["DP250102295"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118525","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:12:14Z","timestamp":1766247134000},"page":"118525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Improved quantitative structure-activity relationship (QSAR) models to predict the activity of hydroxamic acids as HDAC inhibitors against malaria parasites"],"prefix":"10.1016","volume":"305","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-7020","authenticated-orcid":false,"given":"Wisam A.","family":"Dawood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta R.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina S.","family":"Skinner-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hesping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain-Dominique J.P.","family":"Gorse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-8979","authenticated-orcid":false,"given":"Katherine T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118525_bib3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1097\/MS9.0000000000001648","article-title":"Breaking the malaria barrier: the WHO-Approved R21\/Matrix-M vaccine and its global impact - an editorial","volume":"86","author":"Verma","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ejmech.2025.118525_bib4","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S1473-3099(23)00126-3","article-title":"RTS,S\/AS01 malaria vaccine\u2014proven safe and effective?","volume":"23","author":"Bj\u00f6rkman","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118525_bib5","series-title":"Global Malaria Programme Operational Strategy 2024-2030","year":"2024"},{"key":"10.1016\/j.ejmech.2025.118525_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12936-024-05128-1","article-title":"Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile","volume":"23","author":"El Gaaloul","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-12-11","article-title":"Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S\/AS02(D) malaria vaccine in infants living in a malaria-endemic region","volume":"12","author":"Abdulla","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118525_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118525_bib10","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","article-title":"Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis","volume":"3","author":"Kagoro","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejmech.2025.118525_bib11","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118525_bib12","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/S1473-3099(24)00427-4","article-title":"Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug","volume":"24","author":"Bj\u00f6rkman","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118525_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2025.118525_bib14","article-title":"The role of acetylation and deacetylation in cancer metabolism, Clin","volume":"15","author":"Wang","year":"2025","journal-title":"Trans. Med."},{"key":"10.1016\/j.ejmech.2025.118525_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118525_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jmgm.2015.10.006","article-title":"Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors","volume":"62","author":"Melesina","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.118525_bib17","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2025.118525_bib18","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: Belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.seminoncol.2023.03.006","article-title":"Outcomes with panobinostat in heavily pretreated multiple myeloma patients","volume":"50","author":"Pan","year":"2023","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118525_bib20","article-title":"FDA approves an HDAC inhibitor for Duchenne muscular dystrophy","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118525_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1078-0432.CCR-09-1937","article-title":"Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma","volume":"16","author":"Paoluzzi","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143409","article-title":"Valproic acid and breast cancer: state of the art in 2021","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118525_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chom.2014.06.014","article-title":"A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion","volume":"16","author":"Coleman","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2025.118525_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02377-23","article-title":"PfHDAC1 is an essential regulator of P. falciparum asexual proliferation and host cell invasion genes with a dynamic genomic occupancy responsive to artemisinin stress","volume":"15","author":"Kanyal","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2025.118525_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118525_bib26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/febs.14376","article-title":"Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum","volume":"285","author":"Kanyal","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118525_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cmdc.201800808","article-title":"Structure\u2013activity and structure\u2013toxicity relationships of peptoid-based histone deacetylase inhibitors with dual-stage antiplasmodial activity","volume":"14","author":"Mackwitz","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118525_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113065","article-title":"Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity","volume":"211","author":"Mackwitz","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118525_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/acsmedchemlett.5b00468","article-title":"Discovery of a selective series of inhibitors of Plasmodium falciparum HDACs","volume":"7","author":"Ontoria","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118525_bib32","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/AAC.00757-07","article-title":"Potent antimalarial activity of histone deacetylase inhibitor analogues","volume":"52","author":"Andrews","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118525_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpddr.2016.12.005","article-title":"Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth","volume":"7","author":"Chua","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2025.118525_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpddr.2021.08.006","article-title":"Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice","volume":"17","author":"Chua","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2025.118525_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47959-z","article-title":"1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors","volume":"13","author":"Tavares","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118525_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41421-020-00215-4","article-title":"A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1","volume":"6","author":"Huang","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejmech.2025.118525_bib37","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/AAC.00030-12","article-title":"Antimalarial activity of the anticancer histone deacetylase inhibitor SB939","volume":"56","author":"Sumanadasa","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118525_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chembiol.2018.10.001","article-title":"Fragment-based drug discovery: advancing fragments in the absence of crystal structures","volume":"26","author":"Erlanson","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118525_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103052","article-title":"Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models","volume":"24","author":"Mao","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2025.118525_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/acsinfecdis.1c00355","article-title":"QSAR classification models for prediction of hydroxamate histone deacetylase inhibitor activity against malaria parasites","volume":"8","author":"Hesping","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.118525_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13321-024-00842-z","article-title":"Leveraging computational tools to combat malaria: assessment and development of new therapeutics","volume":"16","author":"Ncube","year":"2024","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116776","article-title":"MalariaFlow: a comprehensive deep learning platform for multistage phenotypic antimalarial drug discovery","volume":"277","author":"Lin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2025.118525_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12936-020-03421-3","article-title":"Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria","volume":"19","author":"Potluri","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2024.108716","article-title":"Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites","volume":"258","author":"Dawood","year":"2024","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2025.118525_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2025.100608","article-title":"Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites","volume":"29","author":"Dawood","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2025.118525_bib47","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1021\/acs.jmedchem.1c00821","article-title":"Procainamide\u2013SAHA fused inhibitors of hHDAC6 tackle multidrug-resistant malaria parasites","volume":"64","author":"Nardella","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib48","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","article-title":"Discovery of novel Plasmodium falciparum HDAC1 inhibitors with dual-stage antimalarial potency and improved safety based on the clinical anticancer drug candidate quisinostat","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib49","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1021\/acs.jmedchem.1c01993","article-title":"Drug repurposing of quisinostat to discover novel Plasmodium falciparum HDAC1 inhibitors with enhanced triple-stage antimalarial activity and improved safety","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib50","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib51","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fphar.2018.01275","article-title":"QSAR-Based virtual screening: advances and applications in drug discovery","volume":"9","author":"Neves","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118525_bib52","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1016\/j.csbj.2021.08.011","article-title":"A review on machine learning approaches and trends in drug discovery","volume":"19","author":"Carracedo-Reboredo","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2025.118525_bib54","article-title":"Modelling piperide-based derivatives as potential inhibitors of Plasmodium falciparum lactate dehydrogenase: QSAR and docking studies","volume":"25","author":"Afolabi","year":"2024","journal-title":"Sci. Afr."},{"key":"10.1016\/j.ejmech.2025.118525_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03449","article-title":"QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds","volume":"6","author":"Mahmud","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118525_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13065-025-01395-4","article-title":"Development and experimental validation of a machine learning model for the prediction of new antimalarials","volume":"19","author":"Kore","year":"2025","journal-title":"BMC Chem"},{"key":"10.1016\/j.ejmech.2025.118525_bib57","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/acsmedchemlett.3c00369","article-title":"MAIP: an open-source tool to enrich high-throughput screening output and identify novel, druglike molecules with antimalarial activity","volume":"14","author":"Bosc","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118525_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13321-021-00487-2","article-title":"MAIP: a web service for predicting blood\u2010stage malaria inhibitors","volume":"13","author":"Bosc","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib59","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/acsmedchemlett.4c00323","article-title":"Innovative multistage ML-QSAR models for malaria: from data to discovery","volume":"15","author":"Borba","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118525_bib60","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.cclet.2020.12.023","article-title":"Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118525_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117985","article-title":"Design, synthesis and therapeutic evaluation of novel antimalarial derivatives based on the clinical antitumor candidate drug Quisinostat","volume":"115","author":"Song","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13321-021-00519-x","article-title":"Benchmarks for interpretation of QSAR models","volume":"13","author":"Matveieva","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13040-023-00322-4","article-title":"The Matthews correlation coefficient (MCC) should replace the ROC AUC as the standard metric for assessing binary classification","volume":"16","author":"Chicco","year":"2023","journal-title":"BioData Min."},{"key":"10.1016\/j.ejmech.2025.118525_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","article-title":"The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation","volume":"21","author":"Chicco","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.ejmech.2025.118525_bib65","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118525_bib66","series-title":"Rstudio: Integrated Development for R. Rstudio","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118525_bib67","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41598-024-84342-y","article-title":"Application of the Lasso regularisation technique in mitigating overfitting in air quality prediction models","volume":"15","author":"Pak","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118525_bib68","author":"Friedman"},{"key":"10.1016\/j.ejmech.2025.118525_bib69","article-title":"VIF: VIF regression: a fast regression alogrithm for large data","author":"Lin","year":"2022","journal-title":"R package"},{"key":"10.1016\/j.ejmech.2025.118525_bib70","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.ejmech.2025.118525_bib71","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1038\/s41598-019-45522-3","article-title":"QSAR classification models for predicting the activity of inhibitors of beta-secretase (BACE1) associated with alzheimer's disease","volume":"9","author":"Ponzoni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118525_bib72","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1023\/A:1015952613760","article-title":"An electrotopological-state index for atoms in molecules","volume":"7","author":"Kier","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib73","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/qsar.200610151","article-title":"Principles of QSAR models validation: internal and external","volume":"26","author":"Gramatica","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.ejmech.2025.118525_bib74","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1063\/1.434593","article-title":"Information theory, distance matrix, and molecular branching","volume":"67","author":"Bonchev","year":"1977","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118525_bib75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib76","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.118525_bib77","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118525_bib78","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib79","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/cb400912x","article-title":"An overview of Australia's compound management facility: the Queensland compound library","volume":"9","author":"Simpson","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118525_bib80","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41598-020-59298-4","article-title":"Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites","volume":"10","author":"Coetzee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118525_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13321-022-00599-3","article-title":"Transformer-based molecular optimization beyond matched molecular pairs","volume":"14","author":"He","year":"2022","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad503","article-title":"CMMS-GCL: cross-modality metabolic stability prediction with graph contrastive learning","volume":"39","author":"Du","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118525_bib83","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.3390\/molecules17054791","article-title":"Comparison of different approaches to define the applicability domain of QSAR models","volume":"17","author":"Sahigara","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118525_bib84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2353\/ajpath.2010.091176","article-title":"Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice","volume":"177","author":"Kumar","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2025.118525_bib85","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.leukres.2010.10.030","article-title":"Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia","volume":"35","author":"Jenkins","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib86","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1021\/acs.jmedchem.8b01825","article-title":"Discovery of novel dual histone deacetylase and mammalian target of rapamycin target inhibitors as a promising strategy for cancer therapy","volume":"62","author":"Chen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib87","doi-asserted-by":"crossref","first-page":"890","DOI":"10.18632\/oncotarget.28254","article-title":"CUDC907, a dual phosphoinositide-3 kinase\/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells","volume":"13","author":"Huegel","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118525_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.580407","article-title":"CC-223, NSC781406, and BGT226 exerts a cytotoxic effect against pancreatic cancer cells via mTOR signaling","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118525_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500086","article-title":"Hybrid molecules as efficient drugs against multidrug-resistant malaria parasites","author":"Robert","year":"2025","journal-title":"ChemMedChem n\/a"},{"key":"10.1016\/j.ejmech.2025.118525_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106706","article-title":"Recent developments in the synthesis of hybrid antimalarial drug discovery","volume":"139","author":"Prasad Raiguru","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib91","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/med.21643","article-title":"Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum","volume":"40","author":"Feng","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118525_bib92","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jm301355j","article-title":"Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif","volume":"56","author":"Wagner","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib93","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/acs.biochem.8b00367","article-title":"Entropy as a driver of selectivity for inhibitor binding to histone deacetylase 6","volume":"57","author":"Porter","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118525_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061375","article-title":"The light and dark sides of virtual screening: what is there to know?","volume":"20","author":"Gimeno","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118525_bib95","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bi992245y","article-title":"Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor","volume":"39","author":"Chen","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118525_bib96","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1128\/IAI.73.11.7548-7557.2005","article-title":"Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and Ilomastat block Bacillus anthracis lethal factor activity in viable cells","volume":"73","author":"Kocer Salih","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2025.118525_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0163-7258(97)00023-5","article-title":"Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat","volume":"75","author":"Rasmussen","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118525_bib98","doi-asserted-by":"crossref","first-page":"40719","DOI":"10.18632\/oncotarget.5825","article-title":"Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3\/MMP-13 up-regulation","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118525_bib99","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/cmdc.201000276","article-title":"Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin","volume":"5","author":"Behrendt","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118525_bib100","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/jm5019719","article-title":"Prodrugs of reverse fosmidomycin analogues","volume":"58","author":"Br\u00fccher","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib101","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/jm500850y","article-title":"Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC","volume":"57","author":"Konzuch","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib102","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1021\/jm501323a","article-title":"Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors","volume":"57","author":"Mistry","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib103","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/acs.jmedchem.8b01310","article-title":"Hydroxamic acid inhibitors provide cross-species inhibition of plasmodium M1 and M17 aminopeptidases","volume":"62","author":"Vinh","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000123","article-title":"Two- and three-dimensional quantitative structure-activity relationship models based on conformer structures","volume":"40","author":"Nitta","year":"2021","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2025.118525_bib105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156802610790232260","article-title":"3D-QSAR in drug design--a review","volume":"10","author":"Verma","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib106","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1039\/b606365a","article-title":"3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues","volume":"4","author":"Juvale","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.118525_bib107","first-page":"606","article-title":"Mechanistic insights into the binding of class IIa HDAC inhibitors toward spinocerebellar ataxia Type-2: a 3D-QSAR and pharmacophore modeling approach","volume":"10","author":"Sinha","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118525_bib108","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo7219","article-title":"The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages","volume":"14","author":"Arendse","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118525_bib109","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.pt.2018.06.003","article-title":"PIK-ing new malaria chemotherapy","volume":"34","author":"Hassett","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2025.118525_bib110","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1158\/1078-0432.CCR-11-3165","article-title":"A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors","volume":"18","author":"Banerji","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118525_bib111","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-Selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.118525_bib112","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cmdc.202100176","article-title":"Repurposing anticancer drugs to tackle malaria","volume":"16","author":"Le Govic","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118525_bib113","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12936-024-04855-9","article-title":"Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum","volume":"23","author":"Reyser","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.118525_bib114","series-title":"Pipeline Pilot","author":"Biovia","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118525_bib115","article-title":"Hmisc: Harrell miscellaneous","author":"Harrel","year":"2022","journal-title":"R package"},{"key":"10.1016\/j.ejmech.2025.118525_bib116","author":"Wei"},{"key":"10.1016\/j.ejmech.2025.118525_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.ejmech.2025.118525_bib118","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-024-00837-w","article-title":"Mind your prevalence","volume":"16","author":"Guesn\u00e9","year":"2024","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib119","author":"Landrum"},{"key":"10.1016\/j.ejmech.2025.118525_bib120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13321-019-0405-0","article-title":"The rcdk and cluster R packages applied to drug candidate selection","volume":"12","author":"Voicu","year":"2020","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.118525_bib121","article-title":"Fingerprint: functions to operate on binary fingerprint data","author":"Guha","year":"2018","journal-title":"R package"},{"key":"10.1016\/j.ejmech.2025.118525_bib122","article-title":"Pheatmap: pretty heatmaps","author":"Kolde","year":"2025","journal-title":"R package version 1.0.13"},{"key":"10.1016\/j.ejmech.2025.118525_bib123","article-title":"RxnSim: functions to compute chemical reaction similarity","author":"Varun","year":"2022","journal-title":"R package"},{"key":"10.1016\/j.ejmech.2025.118525_bib124","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.118525_bib125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2025.118525_bib126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:40:50Z","timestamp":1773967250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":124,"alternative-id":["S0223523425012905"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118525","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved quantitative structure-activity relationship (QSAR) models to predict the activity of hydroxamic acids as HDAC inhibitors against malaria parasites","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118525"}}